PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Along this line, also when moving toward higher‐risk patients, a Japanese study on a cohort of 477 patients with histological diagnosis of MASLD reported that a higher incidence of cardiovascular events was independently predicted not only by the severity of liver fibrosis but also by the presence of PNPLA3 C allele [87].